Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen vs Sufentanil for Analgesia in Gynecologic Surgery Patients with Motion Sickness
NCT06232785Phase 4Completed
- Sponsor
- The Second Hospital of Jilin University
- Start
- Feb 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ibuprofen in postoperative pain (2 arms), sponsored by The Second Hospital of Jilin University. Primary endpoints: Incidence of postoperative nausea and vomiting at 24 hours, Visual Analogue Scale Pain Score at 24 hours and 1 more. Started Feb 2022; status: completed.
02
Drugs
ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06232785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06232785.